Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PBRM1 | Q86U86 | 12/20 | 0.49 |
| ▸ | SMARCA2 | P51531 | 10/20 | 0.49 |
| ▸ | SMARCA4 | P51532 | 10/20 | 0.49 |
| ▸ | NR1I2 | O75469 | 5/20 | 0.48 |
| ▸ | DDB1 | Q16531 | 8/20 | 0.47 |
| ▸ | CRBN | Q96SW2 | 8/20 | 0.47 |
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31103345 | 0.93 | DDB1 (0.58) | PBRM1SMARCA2SMARCA4NR1I2DDB1 | |
| SCHEMBL31103175 | 0.88 | DDB1 (0.58) | PBRM1SMARCA2SMARCA4NR1I2DDB1 | |
| SCHEMBL31101034 | 0.87 | PBRM1 (0.51) | PBRM1SMARCA2SMARCA4NR1I2DDB1 | |
| SCHEMBL31099599 | 0.85 | CRBN (0.54) | PBRM1SMARCA2SMARCA4NR1I2DDB1 | |
| SCHEMBL31102039 | 0.82 | PBRM1 (0.49) | PBRM1SMARCA2SMARCA4NR1I2DDB1 | |
| SCHEMBL31101965 | 0.82 | PBRM1 (0.53) | PBRM1SMARCA2SMARCA4NR1I2DDB1 | |
| SCHEMBL31101716 | 0.82 | PBRM1 (0.47) | PBRM1SMARCA2SMARCA4NR1I2DDB1 | |
| SCHEMBL31101492 | 0.80 | PBRM1 (0.51) | PBRM1SMARCA2SMARCA4NR1I2BRD4 | |
| SCHEMBL31103479 | 0.80 | DDB1 (0.43) | PBRM1SMARCA2SMARCA4DDB1CRBN | |
| SCHEMBL23301555 | 0.79 | PBRM1 (0.42) | PBRM1SMARCA2SMARCA4DDB1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678638-A1 | NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-01-14 | — | — | EP | claimed |
| WO-2024188209-A1 | NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-09-19 | — | — | WO | claimed |